etoposide has been researched along with AIDS-Related Opportunistic Infections in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Borok, MZ; Burger, H; Busakhala, NW; Campbell, TB; Caruso, SR; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kosgei, J; Krown, SE; MacPhail, P; Matining, RM; Mngqibisa, R; Moser, CB; Mwelase, N; Nokta, M; Nyirenda, M; Okuku, FM; Oliver, VO; Samaneka, W | 1 |
| Ambinder, R; Borok, M; Bukuru, A; Busakhala, N; Campbell, TB; Dittmer, DP; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kang, M; Krown, SE; Langat, D; MacRae, J; Martin, JN; Martínez-Maza, O; Mngqbisa, R; Moses, A; Mwelase, N; Nokta, M; Nyirenda, M; Orem, J; Samaneka, W; Umbleja, T | 1 |
| Chen, Q; Huang, JZ; Liang, JG; Lin, D; Shi, CM; Zhong, DT | 1 |
| Diehl, V; Franzen, C; Hartmann, P; Rehwald, U; Salzberger, B; Sieber, M; Wöhrmann, A | 1 |
| Bezwoda, WR; Lachter, J; Spencer, D; Stein, ME | 1 |
| Azar, N; Binet, JL; Boccaccio, C; Charlotte, F; Gabarre, J; Gentilini, M; Gonzalez, H; Jouan, M; Leblond, V; Sutton, L | 1 |
| Hanau, L; Henry, DH; Hu, X; Reddy, DM; Sarta, C; Sparano, JA; Wiernik, PH | 1 |
| Albrecht, H; Berger, J; Meigel, W; Plettenberg, A; Stellbrink, HJ; Stoehr, A; van Dyk, U | 1 |
3 trial(s) available for etoposide and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Topics: Adult; Africa; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Developing Countries; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Paclitaxel; Progression-Free Survival; Sarcoma, Kaposi; Vincristine | 2020 |
As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
Topics: Administration, Oral; Adult; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Biopsy; Etoposide; Female; Health Resources; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Sarcoma, Kaposi; Skin; South America | 2018 |
BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV Infections; Hodgkin Disease; Humans; Immunocompromised Host; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; RNA; Treatment Outcome; Vincristine | 2003 |
5 other study(ies) available for etoposide and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Male; Retrospective Studies; Sarcoma, Kaposi; Thrombocytopenia; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine | 2012 |
Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dactinomycin; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Sarcoma, Kaposi; Skin Neoplasms; South Africa; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Duodenal Neoplasms; Etoposide; Humans; Immunocompromised Host; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Neoplasms, Second Primary; Pancytopenia; Remission Induction; Salvage Therapy; Thigh; Transplantation Conditioning; Vincristine | 1996 |
Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cause of Death; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphocyte Subsets; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Risk; Survival Analysis | 1997 |
Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Candidiasis; Case-Control Studies; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Doxorubicin; Esophagitis; Etoposide; Follow-Up Studies; HIV Infections; Humans; Male; Pneumonia, Pneumocystis; Prognosis; Prospective Studies; Risk Factors; Sarcoma, Kaposi; Skin Neoplasms; Vinblastine; Vincristine | 1997 |